0001104659-20-038882.txt : 20200326
0001104659-20-038882.hdr.sgml : 20200326
20200326170220
ACCESSION NUMBER: 0001104659-20-038882
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200324
FILED AS OF DATE: 20200326
DATE AS OF CHANGE: 20200326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHADE CHRISTIAN S
CENTRAL INDEX KEY: 0001214496
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 20746809
MAIL ADDRESS:
STREET 1: MEDAREX
STREET 2: 707 STATE ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6095104718
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
a4.xml
4
X0306
4
2020-03-24
0
0001781983
Aprea Therapeutics, Inc.
APRE
0001214496
SCHADE CHRISTIAN S
535 BOYLSTON STREET
BOSTON
MA
02116
1
1
0
0
President & CEO
Stock Option (right to Buy)
35.50
2020-03-24
4
A
0
127000
0
A
2030-03-24
Common Stock
127000
127000
D
Twenty-five percent of these options vest on March 24, 2021, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.
/s/ Scott M. Coiante, attorney-in-fact
2020-03-26